查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1363131

腸道疾病檢測市場規模、佔有率和趨勢分析報告：按疾病類型、地區和細分市場分類的趨勢，2023-2030年

Enteric Disease Testing Market Size, Share & Trends Analysis Report By Disease Type (Bacterial Enteric Diseases, Viral Enteric Diseases, Parasitic Enteric Diseases), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10個工作天內

價格

腸道疾病檢測市場的成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球腸道疾病檢測市場規模將達到46.8億美元，2023年至2030年年複合成長率為2.7%。

在預測期內，對治療霍亂和其他腹瀉病等疾病的快速診斷的需求增加，人口老化伴隨著不衛生的生活條件，以及腸道疾病醫學檢測覆蓋範圍的擴大，預計將推動市場的發展。

這種成長進一步歸因於醫療保健支出的增加、政府的支持措施和疾病患病的增加。衛生條件差以及生活在貧窮線以下而無法獲得衛生食品和水供應的人口不斷增加等經濟和環境因素導致感染發生率不斷上升，推動了市場成長。

根據比爾和梅琳達蓋茲基金會的資料庫，每年約有 50 萬人因腸道疾病死亡，而且這一數字預計還會進一步上升。 75歲以上人口死亡率最高，其次是5歲以下兒童。

世界衛生組織和聯合國兒童基金會等醫療保健聯邦機構為有效管理病死率而採取的策略性舉措預計將推動市場成長。這些機構努力透過開展意識計劃和醫療營來普及這些感染疾病的檢測。也向第三世界國家的當地組織提供財政支持，以幫助減少這些感染疾病的傳播。

腸道疾病檢測市場報告亮點

  • 細菌性腸道疾病檢測市場佔據最大的收益佔有率佔有率，由於這些感染疾病的高發病率，預計在2023年至2030年的預測期內將以最快的年複合成長率成長。根據約翰霍普金斯大學彭博公共衛生學院的研究，細菌感染引起的腹瀉年度導致約 4 至 600 萬人死亡。
  • 寄生蟲腸道疾病檢測市場預計將以 1.9%的年複合成長率大幅成長。世界衛生組織估計，年度有超過 2 億人感染藍氏賈第蟲、隱孢子蟲和溶組織蟲等寄生蟲。
  • 由於老年人口增加、移民增加、患者意識層級提高以及相對較高的醫療成本，歐洲在2022年以 39.0%的最大收益佔有率主導市場。
  • 預計2023年至2030年預測期內，亞太地區將以 4.0%的年複合成長率成長最快。日本、中國和印度等國家政府採取的提高意識和推動更高檢測水準的配合措施預計將在預測期內推動市場發展。
  • 產業參與者不斷透過新產品的推出和現有技術的升級來刺激市場。2015年 1月，Biomerica 向美國專利商標局申請了一項用於檢測胃腸道疾病的測試專利。
  • 除了技術創新之外，眾多產業參與者也正攜手合作，發揮各自優勢，結成策略聯盟，以獲得更高的利潤。例如，2017年 5月，Quest Diagnostics 宣布與 PeaceHealth 合作，透過高價值設計和創新來增強其服務。

目錄

第1章 調查方法與範圍

第2章 執行摘要

第3章 疾病檢測市場變數、趨勢與範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 普及和成長預測圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 腸道疾病檢測市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 疾病檢測市場：疾病類型預估及趨勢分析

  • 腸道疾病檢測市場，重點
  • 腸道疾病檢測市場：2022年和2030年趨勢和市場佔有率分析
  • 細菌性腸病
  • 病毒性腸疾病
  • 腸道寄生蟲病

第5章 疾病檢測市場：區域估算及趨勢分析

  • 區域展望
  • 依地區分類的腸道疾病檢測市場：要點
  • 北美洲
    • 2018-2030年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東、非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第6章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭分類
    • Abbott
    • BD
    • Biomerica
    • BIOMERIEUX
    • Bio-Rad Laboratories, Inc.
    • Cepheid
    • Coris BioConcept
    • DiaSorin SpA
    • Meridian Bioscience
    • Quest Diagnostics Incorporated
Product Code: GVR-1-68038-542-7

Enteric Disease Testing Market Growth & Trends:

The global enteric disease testing market size is expected to reach USD 4.68 billion by 2030, registering a CAGR of 2.7% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Increasing demand for rapid diagnosis in order to treat diseases such as cholera, and other diarrheal diseases, rise in the aging population accompanied by unhygienic living conditions, and growing application of medical testing for enteric diseases are expected to drive the market over the forecast period.

The growth is further attributed to rising healthcare expenditure, supportive government initiatives, and augmenting disease prevalence rate. Economic and environmental factors such as poor sanitation and the rising population living below the poverty line with no access to hygienic food and water supply are attributed to the growing incidence rate of the infections and thus propel the market growth.

According to the database of Bill and Melinda Gate Foundation, enteric diseases were responsible for about 500,000 deaths each year and these are anticipated to increase further. The highest mortality rate was observed amongst people above 75 years of age followed by children under 5 years of age.

Strategic initiatives by healthcare federal bodies such as the WHO and UNICEF, to manage the disease fatality effectively are expected to assist market growth. These agencies are working towards promoting widespread testing of people for such infections by conducting awareness programmes and healthcare camps. They also fund local agencies in third world countries to limit the spread of these infections.

Enteric Disease Testing Market Report Highlights:

  • Bacterial enteric disease testing market segment dominated with the largest revenue share and is also expected to grow at the fastest CAGR during the forecast period from 2023 to 2030 due to a higher occurrence of these infections. According to research conducted by Johns Hopkins Bloomberg School of Public Health, around four to six million people die annually due to bacterial infection-induced diarrhea.
  • The parasitic enteric disease testing market is expected to register significant growth with CAGR of 1.9%. The WHO has estimated over 200 million people to be infected annually by parasites such as giardia lamblia, cryptosporidium, and E. histolytica.
  • Europe dominated the market with the largest revenue share of 39.0% in 2022, owing to rising geriatric population base, increasing number of immigrants, and rising patient awareness levels coupled with relatively higher healthcare expenditures in the region.
  • Asia Pacific is expected to grow at the fastest CAGR of 4.0% over the forecast period from 2023 to 2030. Government efforts in countries such as Japan, China, and India to increase awareness and promote higher testing are expected to drive the market over the forecast period.
  • Industry players are constantly fueling the market with new product launches or upgrading the existing technology. In January 2015, Biomerica filed a patent application with the U.S. Patent and Trademark Office for a test used in the detection of gastrointestinal disorder.
  • Apart from technology innovation, many industry players are collaborating to use each other's strengths and are formulating strategic alliances in order to incur higher profits. For instance, in May 2017, Quest diagnostics announced a collaboration with PeaceHealth to enhance the service through high-value design and innovation.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Disease type
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Disease type outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Enteric Disease Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Enteric Disease Testing Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Enteric Disease Testing Market: Disease Type Estimates & Trend Analysis

  • 4.1. Enteric Disease Testing Market, Key Takeaways
  • 4.2. Enteric Disease Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Bacterial Enteric Disease
    • 4.3.1. Bacterial enteric disease market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Viral Enteric Disease
    • 4.4.1. Viral enteric disease market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Rotavirus
      • 4.4.2.1. Rotavirus market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Norovirus
      • 4.4.3.1. Norovirus market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Parasitic Enteric Disease
    • 4.5.1. Parasitic enteric disease market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Enteric Disease Testing Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Outlook
  • 5.2. Enteric Disease Testing Market by Region: Key Takeaway
  • 5.3. North America
    • 5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.3. France
      • 5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.6. Sweden
      • 5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.7. Norway
      • 5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.8. Denmark
      • 5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.2. China
      • 5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.3. India
      • 5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.4. Australia
      • 5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.5. Thailand
      • 5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.6. South Korea
      • 5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.2. Mexico
      • 5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7. MEA
    • 5.7.1. Saudi Arabia
      • 5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.4. Kuwait
      • 5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
    • 6.2.1. Abbott
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. BD
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Biomerica
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. BIOMERIEUX
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. Bio-Rad Laboratories, Inc.
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Cepheid
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Coris BioConcept
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. DiaSorin S.p.A.
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
    • 6.2.9. Meridian Bioscience
      • 6.2.9.1. Company overview
      • 6.2.9.2. Financial performance
      • 6.2.9.3. Product benchmarking
      • 6.2.9.4. Strategic initiatives
    • 6.2.10. Quest Diagnostics Incorporated
      • 6.2.10.1. Company overview
      • 6.2.10.2. Financial performance
      • 6.2.10.3. Product benchmarking
      • 6.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 3 North America enteric disease testing market, by region, 2018 - 2030 (USD Million)
  • Table 4 U.S. enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 5 Canada enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 6 Europe enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 7 Europe enteric disease testing market, by region, 2018 - 2030 (USD Million)
  • Table 8 Germany enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 9 UK enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 10 France enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 11 Italy enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 12 Spain enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 13 Sweden enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 14 Norway enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 15 Denmark enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 16 Asia Pacific enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific enteric disease testing market, by region, 2018 - 2030 (USD Million)
  • Table 18 Japan enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 19 China enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 20 India enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 21 Australia enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 22 Thailand enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 23 South Korea enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 24 Latin America enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 25 Latin America enteric disease testing market, by region, 2018 - 2030 (USD Million)
  • Table 26 Brazil enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 27 Mexico enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 28 Argentina enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 29 Middle East and Africa enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 30 Middle East and Africa enteric disease testing market, by region, 2018 - 2030 (USD Million)
  • Table 31 South Africa enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 33 UAE enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 34 Kuwait enteric disease testing market, by disease type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Enteric disease testing: market outlook
  • Fig. 9 Enteric disease testing competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Enteric disease testing market driver impact
  • Fig. 15 Enteric disease testing market restraint impact
  • Fig. 16 Enteric disease testing market strategic initiatives analysis
  • Fig. 17 Enteric disease testing market: Disease type movement analysis
  • Fig. 18 Enteric disease testing market: Disease type outlook and key takeaways
  • Fig. 19 Bacterial enteric disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Viral enteric disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Rotavirus market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Norovirus market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Parasitic enteric disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Enteric disease testing market: Regional movement analysis
  • Fig. 25 Enteric disease testing market: Regional outlook and key takeaways
  • Fig. 26 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)